Cargando…
Biological Rationale for the Use of PPARγ Agonists in Glioblastoma
Glioblastoma multiforme (GBM) is the most common primary intrinsic central nervous system tumor and has an extremely poor overall survival with only 10% patients being alive after 5 years. There has been interesting preliminary evidence suggesting that diabetic patients receiving peroxisome prolifer...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3953711/ https://www.ncbi.nlm.nih.gov/pubmed/24672773 http://dx.doi.org/10.3389/fonc.2014.00052 |